Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study

Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study

Abstract Background For the two-thirds of patients with epilepsy who achieve seizure remission on antiseizure medications (ASMs), patients and clinicians must weigh the pros and cons of long-term ASM treatment. However, little work has evaluated how often ASM discontinuation occurs in practice. We d...

Full description

Bibliographic Details
Main Authors: Samuel W. Terman, Joshua D. Niznik, Geertruida Slinger, Willem M. Otte, Kees P. J. Braun, Carole E. Aubert, Wesley T. Kerr, Cynthia M. Boyd, James F. Burke
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Neurology
Subjects:
Epilepsy
Antiseizure medications
Administrative claims
Discontinuation
Online Access:https://doi.org/10.1186/s12883-022-02852-6

Similar Items

Similar Items